My understanding is the deal helps show future participants in Reg A offering that financial risks are mitigated by transferring the cost of developing assets to ELMOR. I can see a scenario where once all debts are paid off, AMBS can have a clean slate if ELMOR is unable to fulfill its obligation under the agreement.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links